- Net loss on a GAAP basis was
$2.5 million for the current quarter compared with$4.0 million net loss for the prior year quarter. - EBITDA for the current quarter was negative
$0.48 million compared with negative$0.30 million EBITDA for the prior year quarter which is a 40% improvement when adjusted for a non-recurring expense reduction from an Employee Tax Credit received in Q2 last year and compared with negative$0.70 for the first quarter, a 32% improvement over Q1, 2026
Second Quarter 2026 Financial Results
Total revenue for the second quarter of 2026 was
Direct operating costs and expenses were essentially flat from the prior year quarter of approximately
Net loss attributable to
After adjusting certain cash and non-cash items, current quarter results on a non-GAAP basis were a net loss of approximately
Six Month 2026 Financial Results
Total revenue for the current six-month period was
Direct operating costs and expenses decreased approximately
Net loss attributable to
After adjusting certain cash and non-cash items, the current six month period results on a non-GAAP basis were a net loss of approximately
Balance Sheet
The Company's balance sheet on
The Company’s working capital on
Conference Call and Webcast
The Company will host a conference call with members of the executive management team to discuss these results with additional comments and details at
About
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "ongoing," "could," "estimates," "expects," "intends," "may," "appears," "suggests," "future," "likely," "goal," "plans," "potential," "projects," "predicts," "seeks," "should," "would," "guidance," "confident" or "will" or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the risks discussed in the "Risk Factors" section and elsewhere in the Company's Annual Report on form 10-K for the year ended
For further information please contact:
sburroughs@xcelbrands.com
Non-GAAP net income and non-GAAP diluted EPS are non-GAAP unaudited terms. We define non-GAAP net income as net income (loss) attributable to
Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) attributable to
Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to our results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating our financial results.
Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do. In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this document. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.
| Unaudited Consolidated Statements of Operations | ||||||||||||||||
| (in thousands, except share and per share data) | ||||||||||||||||
| For the Three Months Ended | For the Six Months Ended | |||||||||||||||
| 2026 | 2025 | 2026 | 2025 | |||||||||||||
| Revenues | ||||||||||||||||
| Net licensing revenue | $ | 1,121 | $ | 1,321 | $ | 2,265 | $ | 2,653 | ||||||||
| Direct operating costs and expenses | ||||||||||||||||
| Salaries, benefits and employment taxes | 842 | 984 | 1,714 | 2,070 | ||||||||||||
| Other selling, general and administrative expenses | 1,016 | 912 | 2,218 | 2,109 | ||||||||||||
| Total direct operating costs and expenses | 1,858 | 1,896 | 3,932 | 4,179 | ||||||||||||
| Operating loss before other operating costs and expenses | (737 | ) | (575 | ) | (1,667 | ) | (1,526 | ) | ||||||||
| Other operating costs and expenses | ||||||||||||||||
| Depreciation and amortization | 813 | 899 | 1,706 | 1,799 | ||||||||||||
| Charges related to the sale of the Judith Ripka brand | 35 | - | 96 | - | ||||||||||||
| Loss from equity investments | - | 180 | - | 516 | ||||||||||||
| Operating loss | (1,585 | ) | (1,654 | ) | (3,469 | ) | (3,841 | ) | ||||||||
| Interest and finance expense (income) | ||||||||||||||||
| Interest expense | 640 | 457 | 1,202 | 930 | ||||||||||||
| Other finance charges (income), net | 81 | 30 | 112 | 117 | ||||||||||||
| Loss on early extinguishment of debt | 151 | 1,850 | 151 | 1,850 | ||||||||||||
| Interest and finance expense (income), net | 872 | 2,337 | 1,465 | 2,897 | ||||||||||||
| Loss before income taxes | (2,457 | ) | (3,991 | ) | (4,934 | ) | (6,738 | ) | ||||||||
| Income tax provision (benefit) | 19 | - | 31 | 50 | ||||||||||||
| Net loss | (2,476 | ) | (3,991 | ) | (4,965 | ) | (6,788 | ) | ||||||||
| Net loss attributable to noncontrolling interest | - | (3 | ) | - | (3 | ) | ||||||||||
| Net loss attributable to | $ | (2,476 | ) | $ | (3,988 | ) | $ | (4,965 | ) | $ | (6,785 | ) | ||||
| Loss per common share attributed to | ||||||||||||||||
| Basic and diluted net loss per share | $ | (0.40 | ) | $ | (1.66 | ) | $ | (0.82 | ) | $ | (2.84 | ) | ||||
| Weighted average number of common shares outstanding: | ||||||||||||||||
| Basic and diluted weighted average common shares outstanding | 6,159,232 | 2,403,639 | 6,032,122 | 2,388,694 | ||||||||||||
| Unaudited Consolidated Balance Sheets | ||||||||
| (in thousands, except share and per share data) | ||||||||
| Assets | ||||||||
| Current Assets: | ||||||||
| Cash and cash equivalents | $ | 399 | $ | 1,150 | ||||
| Accounts receivable, net | 623 | 956 | ||||||
| Prepaid expenses and other current assets | 502 | 1,564 | ||||||
| Total current assets | 1,524 | 3,670 | ||||||
| Non-Current Assets: | ||||||||
| Property and equipment, net | 103 | 130 | ||||||
| Operating lease right-of-use assets | 2,609 | 3,005 | ||||||
| Trademarks and other intangibles, net | 26,946 | 31,229 | ||||||
| Other assets | 1,291 | 912 | ||||||
| Total non-current assets | 30,949 | 35,276 | ||||||
| Total Assets | $ | 32,473 | $ | 38,946 | ||||
| Liabilities and Stockholders' Equity | ||||||||
| Current Liabilities: | ||||||||
| Accounts payable | $ | 532 | $ | 621 | ||||
| Accrued expenses and other current liabilities | 404 | 600 | ||||||
| Deferred revenue | 976 | 1,330 | ||||||
| Current portion of operating lease obligation | 1,760 | 1,687 | ||||||
| Current portion of long-term debt | 1,865 | 3,250 | ||||||
| Total current liabilities | 5,537 | 7,488 | ||||||
| Long-Term Liabilities: | ||||||||
| Deferred revenue | 1,333 | 1,778 | ||||||
| Long-term portion of operating lease obligation | 2,777 | 3,678 | ||||||
| Long-term debt, net, less current portion | 10,227 | 9,456 | ||||||
| Other long-term liabilities | 877 | 722 | ||||||
| Total long-term liabilities | 15,214 | 15,634 | ||||||
| Total Liabilities | 20,751 | 23,122 | ||||||
| Commitments and Contingencies | ||||||||
| Stockholders' Equity: | ||||||||
| Preferred stock, | - | - | ||||||
| Common stock, | 6 | 6 | ||||||
| Paid-in capital | 112,523 | 111,660 | ||||||
| Accumulated deficit | (98,670 | ) | (93,705 | ) | ||||
| Total | 13,859 | 17,961 | ||||||
| Noncontrolling interest | (2,137 | ) | (2,137 | ) | ||||
| Total Stockholders' Equity | 11,722 | 15,824 | ||||||
| Total Liabilities and Stockholders' Equity | $ | 32,473 | $ | 38,946 | ||||
| Unaudited Consolidated Statements of Cash Flows | ||||||||
| (in thousands) | ||||||||
| For the Six Months Ended | ||||||||
| 2026 | 2025 | |||||||
| Cash flows from operating activities | ||||||||
| Net loss | $ | (4,965 | ) | $ | (6,788 | ) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
| Depreciation and amortization expense | 1,706 | 1,799 | ||||||
| Asset impairment and other charges related to sale of Judith Ripka brand | 96 | - | ||||||
| Paid in-kind interest expense | 515 | 192 | ||||||
| Amortization of deferred finance costs and other non-cash interest expense | 491 | 176 | ||||||
| Stock-based compensation and cost of licensee warrants | 327 | 238 | ||||||
| Loss from equity investments | - | 516 | ||||||
| Loss on early extinguishment of debt | - | 1,850 | ||||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | 333 | 446 | ||||||
| Prepaid expenses and other current and non-current assets | 167 | 104 | ||||||
| Deferred revenue | (799 | ) | (497 | ) | ||||
| Accounts payable, accrued expenses, accrued income taxes payable, and other current liabilities | (171 | ) | (1,560 | ) | ||||
| Lease-related assets and liabilities | (432 | ) | (282 | ) | ||||
| Other long-term liabilities | - | 8 | ||||||
| Net cash used in operating activities | (2,732 | ) | (3,798 | ) | ||||
| Cash flows from investing activities | ||||||||
| Cash consideration received from sale of Judith Ripka brand assets, net | 2,000 | - | ||||||
| Purchase of property and equipment | - | (10 | ) | |||||
| Net cash provided by (used in) investing activities | 2,000 | (10 | ) | |||||
| Cash flows from financing activities | ||||||||
| Proceeds from issuance of shares through equity line facility, net of transaction costs | 415 | - | ||||||
| Proceeds from long-term debt | 3,006 | 5,670 | ||||||
| Payment of deferred finance costs | (350 | ) | (530 | ) | ||||
| Shares repurchased including vested restricted stock in exchange for withholding taxes | (102 | ) | (116 | ) | ||||
| Payment of long-term debt | (4,110 | ) | (500 | ) | ||||
| Net cash (used in) provided by financing activities | (1,141 | ) | 4,524 | |||||
| Net (decrease) increase in cash and cash equivalents | (1,873 | ) | 716 | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | 2,889 | 1,993 | ||||||
| Cash, cash equivalents, and restricted cash at end of period | $ | 1,016 | $ | 2,709 | ||||
| Reconciliation to amounts on consolidated balance sheets: | ||||||||
| Cash and cash equivalents | 399 | 970 | ||||||
| Restricted cash (reported in other non-current assets) | 617 | 1,739 | ||||||
| Total cash, cash equivalents, and restricted cash | $ | 1,016 | $ | 2,709 | ||||
| Supplemental disclosure of cash flow information: | ||||||||
| Cash paid during the period for interest | $ | 196 | $ | 476 | ||||
| Cash paid during the year for income taxes | $ | 50 | $ | - | ||||
| ($ in thousands) | Three Months Ended | Six Months Ended | |||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
| Net loss attributable to | $ | (2,476 | ) | $ | (3,988 | ) | $ | (4,965 | ) | $ | (6,785 | ) | |||
| Amortization of trademarks | 801 | 876 | 1,677 | 1,751 | |||||||||||
| Loss from equity investments | - | 180 | - | 516 | |||||||||||
| Stock-based compensation and cost of licensee warrants | 182 | 186 | 332 | 352 | |||||||||||
| Loss on early extinguishment of debt | 151 | 1,850 | 151 | 1,850 | |||||||||||
| Charges related to the sale of the Judith Ripka brand | 35 | - | 96 | - | |||||||||||
| Income tax provision (benefit) | 19 | - | 31 | 50 | |||||||||||
| $ | (1,288 | ) | $ | (896 | ) | $ | (2,678 | ) | $ | (2,266 | ) | ||||
| Three Months Ended | Six Months Ended | ||||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
| Diluted loss per share | $ | (0.40 | ) | $ | (1.66 | ) | $ | (0.82 | ) | $ | (2.84 | ) | |||
| Amortization of trademarks | 0.13 | 0.36 | 0.28 | 0.73 | |||||||||||
| Loss from equity investments | - | 0.08 | - | 0.22 | |||||||||||
| Stock-based compensation and cost of licensee warrants | 0.03 | 0.08 | 0.06 | 0.15 | |||||||||||
| Loss on early extinguishment of debt | 0.02 | 0.77 | 0.03 | 0.77 | |||||||||||
| Charges related to the sale of the Judith Ripka brand | 0.01 | - | 0.01 | - | |||||||||||
| Income tax provision | 0.00 | - | 0.00 | 0.02 | |||||||||||
| Non-GAAP diluted EPS | $ | (0.21 | ) | $ | (0.37 | ) | $ | (0.44 | ) | $ | (0.95 | ) | |||
| Non-GAAP weighted average diluted shares | 6,159,232 | 2,403,639 | 6,032,122 | 2,388,694 | |||||||||||
| ($ in thousands) | Three Months Ended | Six Months Ended | |||||||||||||
| 2026 | 2025 | 2026 | 2025 | ||||||||||||
| (Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
| Net loss attributable to | $ | (2,476 | ) | $ | (3,988 | ) | $ | (4,965 | ) | $ | (6,785 | ) | |||
| Interest and finance expense | 872 | 2,337 | 1,465 | 2,897 | |||||||||||
| Accretion of lease liability for exited lease | 35 | 59 | 75 | 120 | |||||||||||
| Income tax provision (benefit) | 19 | - | 31 | 50 | |||||||||||
| State and local franchise taxes | 24 | 6 | 60 | 14 | |||||||||||
| Depreciation and amortization | 813 | 899 | 1,706 | 1,799 | |||||||||||
| Loss from equity investments | - | 180 | - | 516 | |||||||||||
| Charges related to the sale of the Judith Ripka brand | 35 | - | 96 | - | |||||||||||
| Stock-based compensation and cost of licensee warrants | 182 | 186 | 332 | 352 | |||||||||||
| Costs associated with restructuring of operations | 17 | 22 | 17 | 39 | |||||||||||
| Adjusted EBITDA | $ | (479 | ) | $ | (299 | ) | $ | (1,183 | ) | $ | (998 | ) | |||
Source: 